| SELLAS LIFE SCIENCES GRP |
| USA |
| Gesundheit |
| US81642T2096 / A2PU3T |
| RXK3 (Frankfurt) / SLS (NASDAQ) |
| FRA:RXK3, ETR:RXK3, RXK3:GR, NASDAQ:SLS |
| - |
| https://www.sellaslifesci.. |
|
Sellas Life Sciences Group Inc. is a biopharmaceut..
>Volltext.. |
| 214.05 Mio. EUR |
| 193.14 Mio. EUR |
| - |
| -23.38 Mio. EUR |
| -22.58 Mio. EUR |
| -0.28 EUR |
| 0.63 Mio. EUR |
| 21.84 Mio. EUR |
| -26.97 Mio. EUR |
| 4.23 |
| - |
| 30.67% |
| - |
| - |
| - |
| - |
| SELLAS LIFE |
| 27.10.25 |
|
||||
|
||||
|
||||
|